“Efficacy and Safety of Tralokinumab in Adolescents With Moderate-to- Severe Atopic Dermatitis: Results of the Phase 3 ECZTRA 6 Trial”. 2022. SKIN The Journal of Cutaneous Medicine 6 (2): s29. https://doi.org/10.25251/skin.6.supp.s29.